STOCK TITAN

Crescent Capital BDC (CCAP) 10-K Filings

CCAP NASDAQ

Here are the 10-K annual reports from Crescent Capital BDC, Inc. (CCAP) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow CCAP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CCAP filings page.

Rhea-AI Summary

Crescent Capital BDC (CCAP) provides a detailed look at its investment portfolio, which is heavily focused on privately negotiated debt across U.S. and international middle‑market companies. The schedule lists numerous unitranche, senior secured first lien, and second lien term loans and revolvers.

Borrowers span sectors such as health care services, software and IT, insurance, consumer services, commercial and professional services, industrials, and financials, with selected exposure in Europe and Australia. Most instruments reference floating base rates with contractual spreads and, in many cases, PIK (payment‑in‑kind) components, and have maturities extending broadly from 2025 into the early 2030s.

The portfolio also includes delayed draw term loans, unsecured PIK debt, foreign currency exchange contracts with Wells Fargo Bank, and a range of equity positions and partnership interests, giving CCAP a mix of income‑generating loans and potential equity upside.